Report overview
Rapid cancer test is a kind of test, which is used for the rapid diagnosis of cancer.
This report contains market size and forecasts of Rapid Cancer Tests in global, including the following market information:
Global Rapid Cancer Tests Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Rapid Cancer Tests Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Rapid Cancer Tests companies in 2021 (%)
The global Rapid Cancer Tests market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Blood Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rapid Cancer Tests include Abingdon Health, Abbott, Alfa Scientific Designs, NanoEntek, Biomerica, Biosynex, IDL Biotech, Exact Sciences and Firstep Bioresearch, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Rapid Cancer Tests manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rapid Cancer Tests Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Rapid Cancer Tests Market Segment Percentages, by Type, 2021 (%)
Blood Test
Urine Test
Others
Global Rapid Cancer Tests Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Rapid Cancer Tests Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Rapid Cancer Tests Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Rapid Cancer Tests Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rapid Cancer Tests revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Rapid Cancer Tests revenues share in global market, 2021 (%)
Key companies Rapid Cancer Tests sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Rapid Cancer Tests sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abingdon Health
Abbott
Alfa Scientific Designs
NanoEntek
Biomerica
Biosynex
IDL Biotech
Exact Sciences
Firstep Bioresearch
Hologic
LifeAssays
